Truist raised the firm’s price target on Guardian Pharmacy (GRDN) to $24 from $22 and keeps a Buy rating on the shares. The firm is ...
Guardian Pharmacy Services Inc. (GRDN) on Tuesday reported a loss of $122 million in its third quarter. The Atlanta-based company said it had a loss of $2 per share.